Q3 2025 Management View James Davis, Chairman, CEO & President, stated that "Our third quarter performance underscores strong demand for our clinical solutions, our diligent execution to meet customer needs and our commitment to advancing our strategy.

It is financial reporting season, and a few major medtech companies posted third-quarter sales growth. | It is financial reporting season, and Quest Diagnostics and Danaher both reported year-over-year sales growth in the third quarter.

Laboratory operator Quest Diagnostics raised its full-year forecast for profit and revenue on Tuesday, banking on robust demand for its diagnostic tests, after posting strong results for the third quarter.

Quest Diagnostics raised its profit and revenue outlook for the year after strong organic growth and acquisitions boosted its top and bottom lines in the third quarter. The provider of diagnostic information services said Tuesday that organic revenue growth in the latest completed quarter hit 6.8%, while acquisitions boosted the top line higher.

The company’s diagnostic information services revenues increased 13.5% to $2.76 billion, with requisition volume growing 12.5% and revenue per requisition up 0.8%. Cash provided by operations surged 57.4% to $563 million for the quarter.

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among patients by making the testing more accessible. Its Advanced ...

Quest Diagnostics Incorporated stock reached an all-time high of 191.87 USD, marking a significant milestone for the company. According to InvestingPro data, the company maintains a "GREAT" financial health score,